Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-23 6:54 pm Purchase | 2021-11-17 | 13G | Flexion Therapeutics, Inc. FLXN | Newtyn Management, LLC | 4,400,000 8.700% | 4,400,000 (New Position) | Filing History |
| 2021-11-09 3:34 pm Sale | 2021-11-09 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 0 0.000% | -4,109,494 (Position Closed) | Filing History |
| 2021-05-10 2:23 pm Sale | 2021-04-30 | 13G | Flexion Therapeutics, Inc. FLXN | MILLER VALUE PARTNERS LLC | 804,925 1.610% | -4,041,175 (-83.39%) | Filing History |
| 2021-02-16 12:45 pm Purchase | 2021-02-16 | 13G | Flexion Therapeutics, Inc. FLXN | Capital World Investors | 3,823,000 7.800% | 1,312,300 (+52.27%) | Filing History |
| 2021-02-16 11:53 am Sale | 2020-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | MILLER VALUE PARTNERS LLC | 4,846,100 9.830% | -86,775 (-1.76%) | Filing History |
| 2021-02-11 2:40 pm Purchase | 2021-02-11 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 4,109,494 8.300% | 1,940,637 (+89.48%) | Filing History |
| 2021-02-10 07:10 am Purchase | 2020-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | STATE STREET CORP STT | 2,509,784 5.090% | 843,886 (+50.66%) | Filing History |
| 2021-02-10 06:16 am Purchase | 2020-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | Artisan Partners Limited Partnership | 3,076,029 6.200% | 3,076,029 (New Position) | Filing History |
| 2021-01-29 09:57 am Purchase | 2020-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | BlackRock Inc. BLK | 4,339,324 8.800% | 1,274,672 (+41.59%) | Filing History |
| 2021-01-25 5:57 pm Sale | 2021-01-15 | 13D | Flexion Therapeutics, Inc. FLXN | Versant Venture Capital III L.P. | 1,388,683 2.800% | -2,550,409 (-64.75%) | Filing History |
| 2020-02-14 2:28 pm Purchase | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | MILLER VALUE PARTNERS LLC | 4,932,875 12.920% | 823,155 (+20.03%) | Filing History |
| 2020-02-14 2:20 pm Purchase | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | Capital World Investors | 2,510,700 6.500% | 158,000 (+6.72%) | Filing History |
| 2020-02-14 10:19 am Sale | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | GILDER GAGNON HOWE & CO LLC | 429,255 1.120% | -1,960,705 (-82.04%) | Filing History |
| 2020-02-14 09:44 am Sale | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | STATE STREET CORP STT | 1,665,898 4.360% | -469,252 (-21.98%) | Filing History |
| 2020-02-10 1:18 pm Purchase | 2020-02-10 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 2,168,857 5.700% | 2,168,857 (New Position) | Filing History |
| 2020-02-05 11:45 am Purchase | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | BlackRock Inc. BLK | 3,064,652 8.000% | 206,621 (+7.23%) | Filing History |